🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
RZL
$RZLT
🔒 US EquitiesRezolute Inc
AVG HISTORICAL GAP
+1.87%
MAX GAP RECORD
+8.64%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $RZLT
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$RZLT
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Sep 24, 2026 Earnings Release 2026-09-24 (AFTER CLOSE (16:00)) |
+1.27%
|
| Feb 12, 2026 Earnings Release 2026-02-12 (AFTER CLOSE) |
-0.55%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
-1.56%
|
| Sep 17, 2025 Earnings Release 2025-09-17 (AFTER CLOSE) |
-0.13%
|
| May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE) |
-4.90%
|
| Feb 12, 2025 Earnings Release 2025-02-12 (AFTER CLOSE) |
+8.64%
|
| Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE) |
+2.10%
|
| Sep 19, 2024 Earnings Release 2024-09-19 (AFTER CLOSE) |
+8.09%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.4%
Bullish Gaps (7)
Bearish Gaps (3)
Neutral / Flat (2)
📖 Intelligence Summary
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗